EXS73565
EXS73565-001
Phase 1 small_molecule active
Quick answer
EXS73565 for Relapsed or Refractory B-cell Malignancies is a Phase 1 program (small_molecule) at RECURSION PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RECURSION PHARMACEUTICALS, INC.
- Indication
- Relapsed or Refractory B-cell Malignancies
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active